Animal study · Supplements / medicine · 28 Oct 2026
Blood taurine was higher at older ages, and putting it back calmed a danger sensor in lab immune cells
Source: Medical Xpress
What the research found
Medical Xpress posted this on 28 October 2026. Vishwa Deep Dixit, Chenyang Guan, and colleagues at Yale report in Cell (DOI 10.1016/j.cell.2026.09.061) that taurine in human serum was higher at ages 60 to 99 than at ages 20 to 40, the opposite of a simple decline-with-aging guess. This was not a pill trial. In cultured macrophages, the cells released up to 80 percent of their taurine as the NLRP3 danger sensor assembled after signals that included bacterial toxins. Putting taurine back stopped the downstream NLRP3 responses the team measured. Lowering taurine sped NLRP3 inflammation even in young mice. Dixit called the result a first step in how that sensor is switched on, and said translation to older adults is still being studied. A separate calorie-restriction program, CALERIE, has reported that taurine rose during restriction. That is background, not this experiment. Sex was not stated for the serum comparison. The stated human age bands are 20 to 40 and 60 to 99, so this card is not tagged to the 40 to 59 band. The result is not a reason to start a taurine supplement. Not medical advice.
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34